Selected article for: "ChEMBL database and sequence identity"

Author: Duc Duy Nguyen; Kaifu Gao; Jiahui Chen; Rui Wang; Guo-Wei Wei
Title: Potentially highly potent drugs for 2019-nCoV
  • Document date: 2020_2_13
  • ID: g5wpa2ee_25
    Snippet: ChEMBL [14] , an open database that brings chemical, bioactivity, and genomic data together to translate genomic information into effective new drugs, is employed to construct our 2019-nCoV training set. Considering the high sequence identity between viral proteases of 2019-nCoV and SARS-CoV, we take the protease of SARS-CoV as the input target in ChEMBL and a total 115 ChEMBL IDs of the target can be found. The experimental ∆G values of 2019-n.....
    Document: ChEMBL [14] , an open database that brings chemical, bioactivity, and genomic data together to translate genomic information into effective new drugs, is employed to construct our 2019-nCoV training set. Considering the high sequence identity between viral proteases of 2019-nCoV and SARS-CoV, we take the protease of SARS-CoV as the input target in ChEMBL and a total 115 ChEMBL IDs of the target can be found. The experimental ∆G values of 2019-nCoV 115 SARS-CoV protease inhibition compounds range from −10.0 kcal/mol to 7.5 kcal/mol. We exclude compounds with positive values, resulting in a total of 84 SARS-nCoV protease inhibition compounds for our machine learning training. A collection of these 84 compounds is given in the Supplementary Materials.

    Search related documents:
    Co phrase search for related documents
    • ChEMBL input target and genomic information translate: 1
    • ChEMBL input target and high sequence: 1
    • ChEMBL input target and high sequence identity: 1
    • ChEMBL input target and input target: 1
    • ChEMBL input target and kcal mol range: 1
    • ChEMBL input target and open database: 1
    • ChEMBL input target and SARS cov: 1
    • ChEMBL input target and SARS CoV protease: 1
    • ChEMBL input target and SARS CoV viral protease: 1
    • ChEMBL input target and SARS ncov: 1
    • ChEMBL input target and Supplementary material: 1
    • ChEMBL input target and training set: 1
    • ChEMBL input target and training set construct: 1
    • effective new drug and new drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
    • effective new drug and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • effective new drug and SARS CoV protease: 1
    • effective new drug and SARS ncov: 1
    • effective new drug and viral protease: 1